Phenixfin Current Deferred Revenue vs Deferred Long Term Liab Analysis
PFX Stock | USD 46.75 0.47 1.02% |
Phenixfin financial indicator trend analysis is much more than just breaking down Phenixfin prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phenixfin is a good investment. Please check the relationship between Phenixfin Current Deferred Revenue and its Deferred Long Term Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.
Current Deferred Revenue vs Deferred Long Term Liab
Current Deferred Revenue vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phenixfin Current Deferred Revenue account and Deferred Long Term Liab. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Phenixfin's Current Deferred Revenue and Deferred Long Term Liab is -0.06. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Phenixfin, assuming nothing else is changed. The correlation between historical values of Phenixfin's Current Deferred Revenue and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Phenixfin are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Current Deferred Revenue i.e., Phenixfin's Current Deferred Revenue and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | -0.06 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Phenixfin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phenixfin current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phenixfin. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For more information on how to buy Phenixfin Stock please use our How to Invest in Phenixfin guide.At this time, Phenixfin's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 4.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.3 M in 2024.
Phenixfin fundamental ratios Correlations
Click cells to compare fundamentals
Phenixfin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phenixfin fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 306.1M | 225.1M | 218.9M | 239.7M | 215.7M | 204.9M | |
Short Long Term Debt Total | 151.0M | 78.0M | 78.5M | 84.5M | 76.1M | 72.3M | |
Total Current Liabilities | 4.5M | 3.4M | 19.2M | (156.4K) | (140.7K) | (133.7K) | |
Net Debt | 94.4M | 8.6M | 55.8M | 78.5M | 70.7M | 67.2M | |
Cash | 56.5M | 69.4M | 22.8M | 6.0M | 5.4M | 5.1M | |
Non Current Assets Total | 248.8M | 153.0M | 194.2M | 228.0M | 205.2M | 194.9M | |
Liabilities And Stockholders Equity | 306.1M | 225.1M | 218.9M | 239.7M | 215.7M | 204.9M | |
Total Liab | 155.5M | 81.4M | 98.0M | 93.0M | 83.7M | 79.5M | |
Total Current Assets | 57.3M | 72.1M | 24.7M | 11.7M | 10.5M | 10.0M | |
Accumulated Other Comprehensive Income | 150.6M | 143.7M | 120.8M | 146.7M | 168.7M | 177.1M | |
Total Stockholder Equity | 150.6M | 143.7M | 120.8M | 146.7M | 132.0M | 125.4M | |
Current Deferred Revenue | (76.9M) | (77.4M) | (78.0M) | 421.7M | 379.5M | 398.5M | |
Retained Earnings | (521.8M) | (545.2M) | (554.6M) | (548.1M) | (493.3M) | (468.6M) | |
Non Currrent Assets Other | (304.0M) | 788.2K | 729.5K | (226.9M) | (204.2M) | (194.0M) | |
Other Assets | 2.1M | 1.4M | (1.4M) | (6.9B) | (6.3B) | (5.9B) | |
Cash And Short Term Investments | 56.5M | 69.4M | 22.8M | 6.0M | 6.9M | 6.5M | |
Net Receivables | 743.6K | 2.6M | 1.4M | 5.5M | 5.0M | 5.9M | |
Non Current Liabilities Total | 151.0M | 78.0M | 78.9M | 85.2M | 76.7M | 72.9M | |
Other Stockholder Equity | 672.4M | 688.9M | 675.4M | 694.8M | 799.0M | 623.2M | |
Common Stock | 2.7K | 2.5K | 2.1K | 2.1K | 1.9K | 1.8K | |
Other Current Liab | (76.1M) | 1.9M | 578.0K | (7.2M) | (8.3M) | (8.7M) | |
Accounts Payable | 2.1M | 1.4M | 18.6M | 7.2M | 6.5M | 8.5M | |
Short Term Debt | 74.0M | 77.4M | 78.0M | 84.3M | 75.8M | 72.0M | |
Other Liab | 103.6K | 10.5K | 34.0 | 327.9K | 295.1K | 240.8K | |
Net Tangible Assets | 216.4M | 150.6M | 143.7M | 120.8M | 108.8M | 188.4M | |
Net Invested Capital | 301.6M | 221.1M | 198.8M | 231.0M | 207.9M | 354.2M | |
Long Term Investments | 246.7M | 151.6M | 193.0M | 226.5M | 203.8M | 309.4M | |
Capital Stock | 2.7K | 2.5K | 2.1K | 2.1K | 1.9K | 1.8K | |
Other Current Assets | 0.0 | 292.0K | 1.4M | 639.7K | 735.6K | 772.4K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Phenixfin Stock Analysis
When running Phenixfin's price analysis, check to measure Phenixfin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phenixfin is operating at the current time. Most of Phenixfin's value examination focuses on studying past and present price action to predict the probability of Phenixfin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phenixfin's price. Additionally, you may evaluate how the addition of Phenixfin to your portfolios can decrease your overall portfolio volatility.